Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 18,726 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
2,123,045
589,586
558,106
500,756
474,597
518,689
Revenue Growth (YoY)
13%
14%
15%
12%
9%
21%
Cost of Revenue
669,045
302,439
118,279
155,981
92,346
94,338
Gross Profit
1,454,000
287,147
439,827
344,775
382,251
424,351
Selling, General & Admin
780,683
183,020
228,231
189,084
180,348
208,210
Research & Development
466,005
126,226
122,107
111,722
105,950
133,319
Operating Expenses
1,224,911
291,833
350,289
297,250
285,539
340,737
Other Non Operating Income (Expenses)
--
--
1
--
--
-1
Pretax Income
263,432
-6,518
106,733
57,775
105,442
80,631
Income Tax Expense
3,558
-48,945
20,100
12,461
19,942
-6,522
Net Income
259,874
42,428
86,632
45,314
85,500
87,153
Net Income Growth
-12%
-51%
40%
-26%
0%
134%
Shares Outstanding (Diluted)
1,842.22
1,842.22
1,851.04
1,850.99
1,857.35
1,882.33
Shares Change (YoY)
-2%
-2%
-2%
-3%
-3%
-2%
EPS (Diluted)
141.06
23.03
46.8
24.48
46.03
46.3
EPS Growth
-10%
-50%
43%
-24%
3%
139%
Free Cash Flow
-110,523
-46,140
43,086
-34,768
-72,701
11,048
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
68.48%
48.7%
78.8%
68.85%
80.54%
81.81%
Operating Margin
10.79%
-0.79%
16.04%
9.49%
20.37%
16.12%
Profit Margin
12.24%
7.19%
15.52%
9.04%
18.01%
16.8%
Free Cash Flow Margin
-5.2%
-7.82%
7.72%
-6.94%
-15.31%
2.12%
EBITDA
306,549
16,438
109,185
66,413
114,513
101,595
EBITDA Margin
14.43%
2.78%
19.56%
13.26%
24.12%
19.58%
D&A For EBITDA
77,460
21,124
19,647
18,888
17,801
17,981
EBIT
229,089
-4,686
89,538
47,525
96,712
83,614
EBIT Margin
10.79%
-0.79%
16.04%
9.49%
20.37%
16.12%
Effective Tax Rate
1.35%
750.92%
18.83%
21.56%
18.91%
-8.08%
Follow-Up Questions
What are Daiichi Sankyo Company, Limited's key financial statements?
According to the latest financial statement (Form-10K), Daiichi Sankyo Company, Limited has a total asset of $0, Net loss of $0
What are the key financial ratios for DSNKY?
Daiichi Sankyo Company, Limited's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Daiichi Sankyo Company, Limited's revenue broken down by segment or geography?
Daiichi Sankyo Company, Limited largest revenue segment is Other, at a revenue of 2,723,000,000 in the most earnings release.For geography, Japan is the primary market for Daiichi Sankyo Company, Limited, at a revenue of 580,112,000,000.
Is Daiichi Sankyo Company, Limited profitable?
no, according to the latest financial statements, Daiichi Sankyo Company, Limited has a net loss of $0
Does Daiichi Sankyo Company, Limited have any liabilities?
no, Daiichi Sankyo Company, Limited has liability of 0
How many outstanding shares for Daiichi Sankyo Company, Limited?
Daiichi Sankyo Company, Limited has a total outstanding shares of 0